Get started
JOHNSON & JOHNSONJOHNSON & JOHNSONJOHNSON & JOHNSON

JOHNSON & JOHNSON

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

JNJ trade ideas

Johnson & Johnson earnings tomorrow at 6:40amJohnson & Johnson earnings are tomorrow at 6:40am. My range is low $157, mid $162, high $167. 4th Quarter December 2020 Consensus = EPS: $1.81 Revenue: $21.73 Billion Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny a day for a month it = $5,368,709. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, risk management Beware of analysts motives Emotions & Opinions FOMO : bad timing Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel www.tradingview.com
NYSE:JNJLong
by Options360
JOHNSON & JOHNSON D1Johnson & Johnson Company is one of the largest hygiene products companies. The company's shares have recently reached historic highs. The global pandemic influenced this significantly. Because the company's products at that time were in great demand and the company received quite large profits, which became an incentive for the growth of the company's shares. But most likely this is not the limit and in the near future we will be able to see the next maximum. The situation with the corona virus does not end, but rather picks up a new wave. What the statistics say. And although vaccination has already begun in many countries, it is unlikely that this will quickly solve this problem. Thus, the company's products will be actively sold and continue to further stimulate shares to grow.
NYSE:JNJLong
by StrongBull777